Published in Infect Immun on June 01, 1994
Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest (2003) 3.57
Abandon the mouse research ship? Not just yet! Shock (2014) 2.60
Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun (2004) 2.53
Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun (1995) 2.43
Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun (1999) 2.41
Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med (1998) 2.39
Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun (2002) 1.99
Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun (1995) 1.92
Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun (1998) 1.89
Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun (1999) 1.75
Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun (2005) 1.68
Interleukin-12 in infectious diseases. Clin Microbiol Rev (1997) 1.63
Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun (2006) 1.59
Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun (2000) 1.56
Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun (1994) 1.53
Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts. Ann Rheum Dis (1996) 1.47
Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection. Infect Immun (2006) 1.47
Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun (2006) 1.45
Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect Immun (2005) 1.36
CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells. PLoS Pathog (2009) 1.24
Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Infect Immun (2004) 1.22
Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model. PLoS Pathog (2009) 1.16
The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J Exp Med (2005) 1.15
Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis. Infect Immun (1994) 1.13
Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance. Infect Immun (1997) 1.13
Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc Natl Acad Sci U S A (2006) 1.10
Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10. Infect Immun (2007) 1.10
Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect Immun (2004) 1.08
Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells. Infect Immun (2004) 1.06
Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J Clin Invest (1997) 1.05
TLRs and NODs mRNA expression pattern in healthy mouse eye. Br J Ophthalmol (2005) 1.03
Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity. J Exp Med (2011) 1.02
The rovA mutant of Yersinia enterocolitica displays differential degrees of virulence depending on the route of infection. Infect Immun (2003) 1.02
Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains. Infect Immun (1998) 1.01
Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect Immun (1996) 1.01
Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice. Infect Immun (2000) 0.99
Yersinia pestis V protein epitopes recognized by CD4 T cells. Infect Immun (2005) 0.98
Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect Immun (2007) 0.97
The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches. Infect Immun (2006) 0.95
Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice. Microbes Infect (2008) 0.95
Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica. Infect Immun (2000) 0.93
Defense Mechanisms of Hepatocytes Against Burkholderia pseudomallei. Front Microbiol (2012) 0.92
Community dynamics in the mouse gut microbiota: a possible role for IRF9-regulated genes in community homeostasis. PLoS One (2010) 0.92
The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses. Infect Immun (2006) 0.90
Chitin microparticles for the control of intestinal inflammation. Inflamm Bowel Dis (2012) 0.90
Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2. Proc Natl Acad Sci U S A (2004) 0.90
Colonization of cecum is important for development of persistent infection by Yersinia pseudotuberculosis. Infect Immun (2014) 0.89
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. J Virol (2005) 0.88
Listeria monocytogenes infection in caspase-11-deficient mice. Infect Immun (2002) 0.87
Interferon-γ- and glucocorticoid-mediated pathways synergize to enhance death of CD4(+) CD8(+) thymocytes during Salmonella enterica serovar Typhimurium infection. Immunology (2013) 0.85
Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation. Infect Immun (2010) 0.85
Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines. Infect Immun (2003) 0.84
Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance. Infect Immun (2000) 0.84
New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget (2016) 0.81
In vivo tracking and protective properties of Yersinia-specific intestinal T cells. Clin Exp Immunol (1998) 0.81
Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect Immun (1999) 0.81
Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity. Infect Immun (2012) 0.81
HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines. Infect Immun (2002) 0.80
Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27. Infect Immun (1998) 0.80
Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut. Infect Immun (2010) 0.79
Mitogen-activated protein kinase-dependent interleukin-1α intracrine signaling is modulated by YopP during Yersinia enterocolitica infection. Infect Immun (2011) 0.79
Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection. Clin Diagn Lab Immunol (2000) 0.77
Susceptibility of four inbred mouse strains to a low-pathogenic isolate of Yersinia enterocolitica. Mamm Genome (2008) 0.77
Natural Killer Cells Mediate Protection against Yersinia pseudotuberculosis in the Mesenteric Lymph Nodes. PLoS One (2015) 0.76
Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells. Infect Immun (2015) 0.76
Differential effect of hyperglycaemia on the immune response in an experimental model of diabetes in BALB/cByJ and C57Bl/6J mice: participation of oxidative stress. Clin Exp Immunol (2013) 0.76
Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection. PLoS One (2013) 0.76
Flagellin-mediated protection against intestinal Yersinia pseudotuberculosis infection does not require interleukin-22. Infect Immun (2016) 0.75
Cytoprotective effects of high dose of α-galactosylceramide against activation-induced CD4+ T and CD8+ T cell death as an adjuvant. Int J Clin Exp Pathol (2015) 0.75
Selection of higher order regression models in the analysis of multi-factorial transcription data. PLoS One (2014) 0.75
Spatial and temporal colonization dynamics of segmented filamentous bacteria is influenced by gender, age and experimental infection with Helicobacter hepaticus in Swiss Webster mice. Microbes Infect (2014) 0.75
Far East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen A. Open Forum Infect Dis (2015) 0.75
Hinokitiol Negatively Regulates Immune Responses through Cell Cycle Arrest in Concanavalin A-Activated Lymphocytes. Evid Based Complement Alternat Med (2015) 0.75
Innate Mucosal Immune System Response of BALB/c vs C57BL/6 Mice to Injury in the Setting of Enteral and Parenteral Feeding. JPEN J Parenter Enteral Nutr (2014) 0.75
Insight from molecular, pathological, and immunohistochemical studies on cellular and humoral mechanisms responsible for vaccine-induced protection of rainbow trout against Yersinia ruckeri. Clin Vaccine Immunol (2013) 0.75
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Adhesion receptors of the immune system. Nature (1990) 28.86
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med (1989) 11.36
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med (1990) 6.35
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33
Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infect Dis (1987) 5.48
Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med (1991) 5.04
Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci U S A (1991) 4.95
Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect Immun (1988) 4.61
IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol (1992) 4.43
A functional dichotomy in CD4+ T lymphocytes. Immunol Today (1988) 4.18
Yersinia enterocolitica. N Engl J Med (1989) 4.00
Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol (1984) 4.00
Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science (1992) 3.59
In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun (1992) 3.07
Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid. Infect Immun (1990) 2.95
Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect Immun (1989) 2.60
Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43
Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol (1983) 2.33
Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today (1993) 2.08
Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol (1991) 2.00
Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology (1989) 1.99
In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med Microbiol Immunol (1992) 1.73
T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect Immun (1992) 1.66
Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect Immun (1993) 1.60
Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS (1993) 1.60
Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect Immun (1986) 1.57
The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med (1992) 1.56
Evidence for differential induction of helper T cell subsets during Trichinella spiralis infection. J Immunol (1989) 1.41
Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immunol (1992) 1.34
A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J Immunol Methods (1985) 1.33
Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: evidence for the involvement of T lymphocytes. Immunobiology (1993) 1.33
Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice. Microb Pathog (1993) 1.19
Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology (1993) 1.17
Immunology of leishmaniasis. Curr Opin Immunol (1992) 1.17
The worm and the protozoa: stereotyped responses or distinct antigens? Parasitol Today (1993) 0.95
Multigenic control of resistance to Yersinia enterocolitica in inbred strains of mice. Infect Immun (1988) 0.92
An animal model to study serum immunoglobulin response to infection by Yersinia enterocolitica. Clin Exp Rheumatol (1985) 0.87
Immunobiology of experimental leishmaniasis. Med Microbiol Immunol (1992) 0.85
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (1994) 10.22
The role of cell-mediated immunity in bacterial infections. Rev Infect Dis (1982) 9.26
Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem (1999) 8.16
Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science (1989) 4.19
CD8+ T lymphocytes in intracellular microbial infections. Immunol Today (1988) 4.12
Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol (1984) 4.00
A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens. J Exp Med (1986) 3.92
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun (1987) 3.87
Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76
Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol (1987) 3.68
Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest (2000) 3.58
Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun (1991) 3.54
Biological functions of t cell lines with specificity for the intracellular bacterium Listeria monocytogenes in vitro and in vivo. J Exp Med (1982) 3.52
Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun (1992) 3.47
Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature (1993) 3.47
Mycobacterial protein antigens: a compilation. Mol Microbiol (1992) 3.35
Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun (1990) 3.35
Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens. J Exp Med (1979) 3.31
Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EMBO J (2000) 3.23
Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun (1998) 3.17
Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol (2000) 2.99
Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol (1996) 2.97
Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci U S A (1995) 2.89
Mycobacteria-reactive Lyt-2+ T cell lines. Eur J Immunol (1988) 2.88
Organ distribution of Schmallenberg virus RNA in malformed newborns. Vet Microbiol (2012) 2.83
Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med (1995) 2.80
T cells against a bacterial heat shock protein recognize stressed macrophages. Science (1989) 2.79
Assessment of aldehyde dehydrogenase in viable cells. Blood (1995) 2.77
Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture. J Clin Microbiol (1985) 2.72
Effective protection against Listeria monocytogenes and delayed-type hypersensitivity to listerial antigens depend on cooperation between specific L3T4+ and Lyt 2+ T cells. Infect Immun (1985) 2.70
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science (2001) 2.70
Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev (1999) 2.69
Development of PCR for screening of enteroaggregative Escherichia coli. J Clin Microbiol (1995) 2.66
Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A (2001) 2.56
T- and B-lymphocyte-independent formation of alveolar macrophage-derived multinucleated giant cells in murine Pneumocystis carinii pneumonia. Infect Immun (1996) 2.55
Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol (1995) 2.48
The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today (1991) 2.48
Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun (1993) 2.47
A universal heterologous internal control system for duplex real-time RT-PCR assays used in a detection system for pestiviruses. J Virol Methods (2006) 2.45
Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur J Immunol (1987) 2.45
Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol (1993) 2.43
Listeria monocytogenes-reactive T lymphocyte clones with cytolytic activity against infected target cells. J Exp Med (1986) 2.42
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42
Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J Immunol (1994) 2.39
A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J Exp Med (1990) 2.37
Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol (1989) 2.36
Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol (1998) 2.35
The role of proteases during apoptosis. FASEB J (1996) 2.35
Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur J Immunol (1995) 2.34
Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virus. Vet Microbiol (2007) 2.34
Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol (1983) 2.33
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest (1999) 2.32
Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun (1997) 2.31
Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci U S A (1996) 2.31
Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol Microbiol (1999) 2.28
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun (1994) 2.26
Primary responses of human T cells to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant ligands. Eur J Immunol (1990) 2.25
Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol (1998) 2.25
Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis. J Infect Dis (1983) 2.20
The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent regulation. J Bacteriol (1998) 2.18
Caspases and caspase inhibitors. Trends Biochem Sci (1997) 2.17
Differentiation in virulence patterns of Escherichia coli possessing eae genes. Med Microbiol Immunol (1994) 2.16
The pesticin receptor of Yersinia enterocolitica: a novel virulence factor with dual function. Mol Microbiol (1994) 2.15
Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species. J Clin Microbiol (1998) 2.13
Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J Med Microbiol (1994) 2.08
Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity. Eur J Immunol (1983) 2.06
Antigen-specific Lyt-2+ cytolytic T lymphocytes from mice infected with the intracellular bacterium Listeria monocytogenes. J Immunol (1986) 2.04
Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol (1995) 2.04
Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A (1977) 2.01
Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina. Exp Cell Res (1981) 1.99
Vitamin-D status in long-stay geriatric patients. Lancet (1975) 1.98
Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol (1989) 1.97
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med (2013) 1.96
Acquired resistance to facultative intracellular bacteria: relationship between persistence, cross-reactivity at the T-cell level, and capacity to stimulate cellular immunity of different Listeria strains. Infect Immun (1984) 1.96
Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia (2006) 1.95
T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. J Immunol (1989) 1.94
[HYGEA (Hygiene in gastroenterology--endoscope reprocessing): Study on quality of reprocessing flexible endoscopes in hospitals and in the practice setting]. Z Gastroenterol (2002) 1.93
Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol (1998) 1.93
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol (1993) 1.92
Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol (2000) 1.91
Substitution of two histidine residues in YadA protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence. Mol Microbiol (1995) 1.91
Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol (2003) 1.86
Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85
Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun (1997) 1.85
The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst (1993) 1.84
Persistence of Yersinia enterocolitica in man. Infection (1988) 1.83
Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages. Infect Immun (1988) 1.80
Phage-associated cytotoxin production by and enteroadhesiveness of enteropathogenic Escherichia coli isolated from infants with diarrhea in West Germany. J Infect Dis (1987) 1.79
High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr (1991) 1.78
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol (1995) 1.75
Characterization of the major polypeptides of the rat liver nuclear envelope. J Biol Chem (1983) 1.75
Immune responses to intracellular bacteria. Curr Opin Immunol (2001) 1.75
IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol (1998) 1.73
Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol (2000) 1.73
In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med Microbiol Immunol (1992) 1.73
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun (1993) 1.72